The Blood Glucose Monitoring Devices Market is expected to reach $21.71 billion by 2030 at a CAGR of 7.5% from 2023 to 2030. Blood glucose monitoring devices are used for managing diabetes and monitoring the blood glucose levels of diabetic patients. These devices allow patients to monitor their blood glucose levels in a convenient and minimally invasive manner. The devices perform a quantitative test and provide data on the amount of glucose present in the blood. It helps the patients to manage the disease by monitoring their blood glucose levels and getting medical help when needed.
The growth of this market is driven by the rising prevalence of diabetes, the increasing number of people living unhealthy & sedentary lifestyles, and product innovations in diabetes care. In addition, the growing demand for non-invasive glucose monitoring devices and increasing awareness regarding diabetic health in developing countries are expected to provide significant growth opportunities for this market.
However, the insurance coverage and reimbursement scenarios and product recalls are expected to hinder the growth of this market. In addition, factors such as the large number of people living with undiagnosed diabetes and the high costs of continuous glucose monitoring devices are major challenges to the market’s growth.
Click here to: Get a Free Sample Copy of this report
Increasing Prevalence of Diabetes to Drive Market Growth
Diabetes is a chronic disease that occurs when the pancreas does not produce enough insulin or cannot effectively use it effectively to regulate body sugar. According to the International Diabetes Federation, in 2021, the global prevalence of diabetes was estimated to be 537 million, and it is projected to increase to 643 million by 2030 and 783 million by 2045. The significant growth in the diabetic population is primarily attributed to the increasing number of people living sedentary lifestyles with poor diets and lowered physical inactivity. Diabetes prevalence has risen more rapidly in low- and middle-income countries than in high-income countries. These factors are expected to boost the demand for blood glucose monitoring devices in the coming years.
Significant Growth in the Adoption of Continuous Glucose Monitoring Devices Observed in Recent Years
Continuous glucose monitoring (CGM) devices measure glucose levels automatically and store the readings in a monitor. Generally, continuous blood glucose monitoring devices consist of a sensor worn on the body and automatically obtain frequent glucose readings. The data are manually scanned or wirelessly transmitted to a nearby receiver to display the readings. Patients and their physicians can assess patterns in glucose fluctuations, which helps them make informed decisions about nutrition, physical activity, and medication.
In recent years, the continuous glucose monitoring segment has witnessed significant growth due to the increasing adoption of these devices. In addition, the rapid advancements in technology and design have also enabled the increased adoption of these devices by patients and healthcare providers. This market is expected to grow further as the devices become easier to use, less intrusive, and less expensive.
Key Findings of the Blood Glucose Monitoring Devices Market Study:
In 2023, the Self-monitoring Devices Segment is Expected to Dominate the Blood Glucose Monitoring Devices Market
Based on product, the blood glucose monitoring devices market is segmented into self-monitoring devices, continuous blood glucose monitoring devices, and other devices & accessories. In 2023, the self-monitoring devices segment is expected to account for the largest share of the blood glucose monitoring devices market. The large market share of this segment is attributed to factors such as the high prevalence of type-2 diabetes, the recurring demand for test strips used in blood glucose monitoring devices, and increased awareness about self-management of diabetes.
In 2023, the Type-2 Diabetes Segment is Expected to Dominate the Blood Glucose Monitoring Devices Market
Based on diabetes type, the blood glucose monitoring devices market is segmented into type-2 diabetes, type-1 diabetes, and gestational diabetes. In 2023, the type-2 diabetes segment is expected to account for the largest share of the blood glucose monitoring devices market. The large market share of this segment is attributed to factors such as the large population of people with type-2 diabetes, the increasing number of people living unhealthy lifestyles without any physical activity, and the high prevalence of obesity.
In 2023, the Self/Home Care Segment is Expected to Dominate the Blood Glucose Monitoring Devices Market
Based on end user, the blood glucose monitoring devices market is segmented into self/home care, hospital & clinics, and other end users. In 2023, the self/home care segment is expected to account for the largest share of the blood glucose monitoring devices market. The large market share of this segment is attributed to factors such as the increased awareness about self-management of diabetes, the high prevalence of diabetes globally, and the cost-effectiveness offered by blood glucose monitoring devices.
In 2023, Asia-Pacific: The Fastest-growing Regional Market
Asia-Pacific is slated to register the fastest growth rate in the blood glucose monitoring devices market during the forecast period. The growth of this regional market is driven by the increasing diabetic population, especially in countries such as India and China, government initiatives to increase awareness about self-diabetes management, and the increasing awareness of diabetes management among the population.
Key Players
The report includes a competitive landscape based on an extensive assessment of the blood glucose monitoring devices market based on product, diabetes type, end user, and geography. The report also provides insights into the geographic presence of major market players and the key growth strategies they adopted between the last four years.
The key players profiled in the blood glucose monitoring devices market are Abbott Laboratories (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland) (Subsidiary of PHC Holdings Corporation), Becton, Dickinson and Company (U.S.), DexCom, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), LifeScan IP Holdings, LLC (Switzerland) (Subsidiary of Platinum Equity, LLC [U.S.]), Medtronic plc (Ireland), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), and Nipro Corporation (Japan), ARKRAY, Inc. (U.S.), Prodigy Diabetes Care, LLC (U.S.), ACON Laboratories, Inc. (U.S.), Nova Biomedical Corporation (U.S.).
Scope of the Report:
Blood Glucose Monitoring Devices Market, by Product
Blood Glucose Monitoring Devices Market, by Diabetes Type
Blood Glucose Monitoring Devices Market, by End User
Blood Glucose Monitoring Devices Market, by Geography
Key questions answered in the report:
This market study covers the market sizes & forecasts of the blood glucose monitoring devices market based on product, diabetes type, end user, and geography. This market study also provides the value analysis of various segments and subsegments of the blood glucose monitoring devices market at the regional and country levels.
The blood glucose monitoring devices market is projected to reach $21.71 billion by 2030, at a CAGR of 7.5% during the forecast period (2023–2030).
Based on product, the blood glucose monitoring devices market is segmented into self-monitoring devices, continuous blood glucose monitoring devices, and other devices. In 2023, the self-monitoring devices segment is expected to account for the largest share of the blood glucose monitoring devices market due to the recurring demand for test strips used in blood glucose monitoring devices, the high prevalence of diabetes globally, and the cost-efficiency of self-monitoring devices.
Based on diabetes type, the blood glucose monitoring devices market is segmented into type-2 diabetes, type-1 diabetes, and gestational diabetes. In 2023, the type-2 diabetes segment is expected to account for the largest share of the blood glucose monitoring devices market due to the large number of people diagnosed with type-2 diabetes and the increasing number of people living diabetes-causing lifestyles such as physical inactivity and smoking tobacco.
Based on end user, the blood glucose monitoring devices market is segmented into self/home care, hospital & clinics, and other end users. In 2023, the self/home care segment is expected to account for the largest share of the blood glucose monitoring devices market due to the high utilization of blood glucose monitoring devices in homecare settings and the advantages offered by blood glucose monitoring devices such as convenience, cost-effectiveness, and ease of use.
The growth of this market is driven by the rising prevalence of diabetes, the increasing number of people living unhealthy & sedentary lifestyles, and product innovations in diabetes care.
In addition, the growing demand for non-invasive glucose monitoring devices and increasing awareness regarding diabetic health in developing countries are expected to provide significant growth opportunities for this market.
However, the insurance coverage and reimbursement scenarios and product recalls are expected to hinder the growth of this market. In addition, factors such as the large number of people living with undiagnosed diabetes and the high costs of continuous glucose monitoring devices are major challenges to the market’s growth.
The key players operating in the blood glucose monitoring devices market include Abbott Laboratories (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland) (A Part of PHC Holdings Corporation), Becton, Dickinson and Company (U.S.), DexCom, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), LifeScan IP Holdings, LLC (Switzerland) (Subsidiary of Platinum Equity, LLC [U.S.]), Medtronic plc (Ireland), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), and Nipro Corporation (Japan), ARKRAY, Inc. (U.S.), Prodigy Diabetes Care, LLC (U.S.), ACON Laboratories, Inc. (U.S.), Nova Biomedical Corporation (U.S.).
The Asia-Pacific region is slated to witness the fastest growth rate during the forecast period and subsequently offer significant growth opportunities for the players operating in this market. The growth of this regional market is driven by the increasing diabetic population, especially in countries such as India and China, government initiatives to increase awareness about self-diabetes management, and the increasing awareness of diabetes management among the population.
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Increasing Prevalence of Diabetes
4.2.2. Increasing Number of People Living Unhealthy & Sedentary Lifestyles
4.2.3. Product Innovations in Diabetes Care
4.3. Restraints
4.3.1. Insurance Coverage and Reimbursement Scenarios
4.3.2. Product Recalls
4.4. Opportunities
4.4.1. Growing Demand for Non-Invasive Glucose Monitoring Devices
4.4.2. Increasing Awareness About Diabetic Health in Developing Countries
4.5. Challenges
4.5.1. Large proportion of People With Undiagnosed Diabetes
4.5.2. High Costs of Continuous Glucose Monitoring Devices
4.6. The Impact of COVID-19 on the Global Blood Glucose Monitoring Devices Market
4.7. Regulatory Analysis
5. Global Blood Glucose Monitoring Devices Market, by Product
5.1. Introduction
5.2. Self-monitoring Devices
5.2.1. Blood Glucose Meters
5.2.2. Test Strips
5.3.3. Lancets
5.3. Continuous Blood Glucose Monitoring Devices
5.3.1 Sensors
5.3.2 Transmitters & Receivers
5.4. Other Devices & Accessories
6. Global Blood Glucose Monitoring Devices Market, by Diabetes Type
6.1. Introduction
6.2. Type-2 Diabetes
6.3. Type-1 Diabetes
6.4. Gestational Diabetes
7. Global Blood Glucose Monitoring Devices Market, by End User
7.1. Introduction
7.2. Self/Home Care
7.3. Hospital & Clinics
7.4. Other End Users
8. Blood Glucose Monitoring Devices Market, by Geography
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe (RoE)
8.4. Asia-Pacific
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. Indonesia
8.4.4. Rest of Asia-Pacific (RoAPAC)
8.5. Latin America
8.5.1. Brazil
8.5.2. Mexico
8.5.3. Argentina
8.5.4. Rest of Latin America
8.6. Middle East & Africa
9. Competitive Landscape
9.1. Introduction
9.2. Key Growth Strategies
9.3. Competitive Dashboard
9.4. Vendor Market Positioning
9.5. Market Share Analysis (2022)
10. Company Profiles (Business Overview, Financial Overview, Product Overview, Strategic Developments)
10.1. Abbott Laboratories
10.2. Ascensia Diabetes Care Holdings AG
10.3. Becton, Dickinson and Company
10.4. DexCom, Inc.
10.5. F. Hoffmann-La Roche Ltd.
10.6. LifeScan IP Holdings, LLC
10.7. Medtronic plc
10.8. Ypsomed Holding AG
10.9. B. Braun Melsungen AG
10.10. Nipro Corporation
10.11. ARKRAY, Inc.
10.12. Prodigy Diabetes Care, LLC
10.13. ACON Laboratories, Inc.
10.14. Nova Biomedical Corporation
10.15. Other Companies
11. Appendix
11.1. Questionnaire
11.2. Available Customization
List of Tables
Table 1 Global Blood Glucose Monitoring Devices Market: Impact Analysis of Market Drivers (2023–2030)
Table 2 Global Blood Glucose Monitoring Devices Market: Impact Analysis of Market Restraints (2023–2030)
Table 3 Global Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 4 Global Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2023–2030 (USD Million)
Table 5 Global Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Country/Region, 2023–2030 (USD Million)
Table 6 Global Blood Glucose Monitoring Devices Market Size for Blood Glucose Meters, by Country/Region, 2023–2030 (USD Million)
Table 7 Global Blood Glucose Monitoring Devices Market Size for Test Strips, by Country/Region, 2023–2030 (USD Million)
Table 8 Global Blood Glucose Monitoring Devices Market Size for Lancets, by Country/Region, 2023–2030 (USD Million)
Table 9 Global Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 10 Global Continuous Blood Glucose Monitoring Market Size for Sensors, by Country/Region, 2021–2030 (USD Million)
Table 11 Global Continuous Blood Glucose Monitoring Market Size for Transmitters & Receivers, by Country/Region, 2021–2030 (USD Million)
Table 12 Global Blood Glucose Monitoring Devices Market Size for Other Devices & Accessories, by Country/Region, 2021–2030 (USD Million)
Table 13 Global Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 14 Global Blood Glucose Monitoring Devices Market Size for Type-2 Diabetes, by Country/Region, 2023–2030 (USD Million)
Table 15 Global Blood Glucose Monitoring Devices Market Size for Type-1 Diabetes, by Country/Region, 2023–2030 (USD Million)
Table 16 Global Blood Glucose Monitoring Devices Market Size for Gestational Diabetes, by Country/Region, 2023–2030 (USD Million)
Table 17 Global Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 18 Global Blood Glucose Monitoring Devices Market Size for Self/Home Care, by Country/Region, 2023–2030 (USD Million)
Table 19 Global Blood Glucose Monitoring Devices Market Size for Hospital & Clinics, by Country/Region, 2023–2030 (USD Million)
Table 20 Global Blood Glucose Monitoring Devices Market Size for Other End Users, by Country/Region, 2023–2030 (USD Million)
Table 21 Global Blood Glucose Monitoring Devices Market Size, by Country/Region, 2021–2030 (USD Million)
Table 22 North America: Blood Glucose Monitoring Devices Market Size, by Country, 2021–2030 (USD Million)
Table 23 North America: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 24 North America: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 25 North America: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 26 North America: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 27 North America: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 28 U.S.: Key Micro-indicators
Table 29 U.S.: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 30 U.S.: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 31 U.S.: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 32 U.S.: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 33 U.S.: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 34 Canada: Key Micro-indicators
Table 35 Canada: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 36 Canada: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 37 Canada: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 38 Canada: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 39 Canada: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 40 Europe: Blood Glucose Monitoring Devices Market Size, by Country/Region, 2021–2030 (USD Million)
Table 41 Europe: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 42 Europe: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 43 Europe: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 44 Europe: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 45 Europe: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 46 Germany: Key Micro-indicators
Table 47 Germany: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 48 Germany: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 49 Germany: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 50 Germany: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 51 Germany: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 52 France: Key Micro-indicators
Table 53 France: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 54 France: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 55 France: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 56 France: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 57 France: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 58 U.K.: Key Micro-indicators
Table 59 U.K.: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 60 U.K.: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 61 U.K.: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 62 U.K.: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 63 U.K.: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 64 Italy: Key Micro-indicators
Table 65 Italy: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 66 Italy: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 67 Italy: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 68 Italy: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 69 Italy: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 70 Spain: Key Micro-indicators
Table 71 Spain: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 72 Spain: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 73 Spain: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 74 Spain: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 75 Spain: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 76 RoE: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 77 RoE: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 78 RoE: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 79 RoE: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 80 RoE: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 81 Asia-Pacific: Blood Glucose Monitoring Devices Market Size, by Country/Region, 2021–2030 (USD Million)
Table 82 Asia-Pacific: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 83 Asia-Pacific: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 84 Asia-Pacific: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 85 Asia-Pacific: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 86 Asia-Pacific: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 87 China: Key Micro-indicators
Table 88 China: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 89 China: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 90 China: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 91 China: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 92 China: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 93 Japan: Key Micro-indicators
Table 94 Japan: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 95 Japan: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 96 Japan: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 97 Japan: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 98 Japan: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 99 India: Key Micro-indicators
Table 100 India: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 101 India: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 102 India: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 103 India: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 104 India: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 105 Indonesia: Key Micro-indicators
Table 106 Indonesia: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 107 Indonesia: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 108 Indonesia: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 109 Indonesia: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 110 Indonesia: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 111 RoAPAC: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 112 RoAPAC: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 113 RoAPAC: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 114 RoAPAC: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 115 RoAPAC: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 116 Latin America: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 117 Latin America: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 118 Latin America: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 119 Latin America: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 120 Latin America: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 121 Brazil: Key Micro-indicators
Table 122 Brazil: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 123 Brazil: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 124 Brazil: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 125 Brazil: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 126 Brazil: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 127 Mexico: Key Micro-indicators
Table 128 Mexico: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 129 Mexico: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 130 Mexico: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 131 Mexico: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 132 Mexico: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 133 Argentina: Key Micro-indicators
Table 134 Argentina: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 135 Argentina: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 136 Argentina: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 137 Argentina: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 138 Argentina: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 139 RoLATAM: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 140 RoLATAM: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 141 RoLATAM: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 142 RoLATAM: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 143 RoLATAM: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 144 Middle East & Africa: Blood Glucose Monitoring Devices Market Size, by Product, 2021–2030 (USD Million)
Table 145 Middle East & Africa: Blood Glucose Monitoring Devices Market Size for Self-monitoring Devices, by Type, 2021–2030 (USD Million)
Table 146 Middle East & Africa: Continuous Blood Glucose Monitoring Devices Market Size, by Type, 2021–2030 (USD Million)
Table 147 Middle East & Africa: Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2021–2030 (USD Million)
Table 148 Middle East & Africa: Blood Glucose Monitoring Devices Market Size, by End User, 2021–2030 (USD Million)
Table 149 Recent Developments, by Company (2020–2023)
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Blood Glucose Monitoring Devices Market Size, by Product, 2023 Vs. 2030 (USD Million)
Figure 8 Global Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2023 Vs. 2030 (USD Million)
Figure 9 Global Blood Glucose Monitoring Devices Market Size, by End User, 2023 Vs. 2030 (USD Million)
Figure 10 Blood Glucose Monitoring Devices Market Size, by Geography
Figure 11 Market Dynamics
Figure 12 Global Blood Glucose Monitoring Devices Market Size, by Product, 2023 Vs. 2030 (USD Million)
Figure 13 Global Blood Glucose Monitoring Devices Market Size, by Diabetes Type, 2023 Vs. 2030 (USD Million)
Figure 14 Global Blood Glucose Monitoring Devices Market Size, by End User, 2023 Vs. 2030 (USD Million)
Figure 15 Global Blood Glucose Monitoring Devices Market Size, by Region, 2023 Vs. 2030 (USD Million)
Figure 16 North America: Blood Glucose Monitoring Devices Market Snapshot
Figure 17 Europe: Blood Glucose Monitoring Devices Market Snapshot
Figure 18 Asia-Pacific: Blood Glucose Monitoring Devices Market Snapshot
Figure 19 Key Growth Strategies Adopted by Leading Players (2020–2023)
Figure 20 Blood Glucose Monitoring Devices Market: Competitive Dashboard
Figure 21 Blood Glucose Monitoring Devices Market: Competitive Benchmarking By Product
Figure 22 Blood Glucose Monitoring Devices Market: Competitive Benchmarking By Geography
Figure 23 Market Share Analysis: Blood Glucose Monitoring Devices Market (2022)
Figure 24 Abbott Laboratories: Financial Overview (2022)
Figure 25 PHC Holdings Corporation: Financial Overview (2022)
Figure 26 Becton, Dickinson and Company: Financial Overview (2022)
Figure 27 DexCom, Inc.: Financial Overview (2022)
Figure 28 F. Hoffmann-La Roche Ltd.: Financial Overview (2022)
Figure 29 Medtronic plc.: Financial Overview (2022)
Figure 30 Ypsomed Holding AG: Financial Overview (2022)
Figure 31 Nipro Corporation: Financial Overview (2022)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Jan-2023
Published Date: Mar-2023
Published Date: Jul-2020
